Articles with public access mandates - Van Den Anker JLearn more
Not available anywhere: 34
Morphine glucuronidation in preterm neonates, infants and children younger than 3 years
CAJ Knibbe, EHJ Krekels, JN van den Anker, J DeJongh, GWE Santen, ...
Clinical pharmacokinetics 48, 371-385, 2009
Mandates: US National Institutes of Health
Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science
JS Leeder, GL Kearns, SP Spielberg, J van den Anker
The Journal of Clinical Pharmacology 50 (12), 1377-1387, 2010
Mandates: US National Institutes of Health
Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates
M Wilbaux, A Fuchs, J Samardzic, F Rodieux, C Csajka, K Allegaert, ...
The Journal of Clinical Pharmacology 56 (8), 909-935, 2016
Mandates: US National Institutes of Health, Research Foundation (Flanders)
An algorithm to detect adverse drug reactions in the neonatal intensive care unit
W Du, VT Lehr, M Lieh‐Lai, W Koo, RM Ward, MJ Rieder, ...
The Journal of Clinical Pharmacology 53 (1), 87-95, 2013
Mandates: US National Institutes of Health
Pharmacokinetic studies in neonates: the utility of an opportunistic sampling design
S Leroux, MA Turner, CBL Guellec, H Hill, JN van den Anker, GL Kearns, ...
Clinical pharmacokinetics 54, 1273-1285, 2015
Mandates: National Institute for Health Research, UK
In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age
K Allegaert, S Vanhaesebrouck, R Verbesselt, JN van den Anker
Therapeutic drug monitoring 31 (4), 411-415, 2009
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography–electrospray ionization …
SF Cook, AD King, JN van den Anker, DG Wilkins
Journal of Chromatography B 1007, 30-42, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method
K Allegaert, M Kuppens, D Mekahli, E Levtchenko, F Vanstapel, ...
The Journal of Maternal-Fetal & Neonatal Medicine 25 (9), 1678-1681, 2012
Mandates: Research Foundation (Flanders)
The amikacin research program: a stepwise approach to validate dosing regimens in neonates
A Smits, A Kulo, J van den Anker, K Allegaert
Expert opinion on drug metabolism & toxicology 13 (2), 157-166, 2017
Mandates: Research Foundation (Flanders)
Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology
K Allegaert, SHP Simons, D Tibboel, EH Krekels, CA Knibbe, ...
European Journal of Pharmaceutical Sciences 109, S27-S31, 2017
Mandates: Research Foundation (Flanders), Netherlands Organisation for Health Research …
Possible effects of repeated exposure to ibuprofen and acetaminophen on the intestinal immune response in young infants
JP Langhendries, K Allegaert, JN Van Den Anker, F Veyckemans, ...
Medical hypotheses 87, 90-96, 2016
Mandates: Research Foundation (Flanders)
Neonatal withdrawal syndrome: reaching epidemic proportions across the globe
K Allegaert, JN van den Anker
Archives of Disease in Childhood-Fetal and Neonatal Edition 101 (1), 2-3, 2016
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Comorbidity of migraine and epilepsy in pediatrics: a review
J Jancic, V Djuric, B Hencic, JN van den Anker, J Samardzic
Journal of child neurology 33 (12), 801-808, 2018
Mandates: US National Institutes of Health, Ministry of Education, Science and …
Severity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia
P Pokorná, L Posch, M Šíma, P Klement, O Slanar, J van den Anker, ...
The Journal of Maternal-Fetal & Neonatal Medicine 32 (14), 2302-2309, 2019
Mandates: Research Foundation (Flanders)
Optimising β-lactam dosing in neonates: a review of pharmacokinetics, drug exposure and pathogens
A Fuchs, G Li, JN Anker, J Bielicki
Current pharmaceutical design 23 (38), 5805-5838, 2017
Mandates: US National Institutes of Health
Pharmacokinetics and pharmacodynamics of intravenous acetaminophen in neonates
K Allegaert, J Van Den Anker
Expert Review of Clinical Pharmacology 4 (6), 713-718, 2011
Mandates: Research Foundation (Flanders)
Availability of oral formulations labeled for use in young children in Serbia, Germany and the USA
M Bajcetic, G L Kearns, I Jovanovic, M Brajovic, J N van den Anker
Current Pharmaceutical Design 21 (39), 5668-5673, 2015
Mandates: US National Institutes of Health
Creatinine-based vancomycin dosing regimens in neonates: there is more to consider than the variation in drug assay.
K Allegaert, JN Anker, B Meibohm, SJ Phelps, N Mehrotra, L Tang
Pharmacotherapy 32 (9), 2012
Mandates: US National Institutes of Health, Research Foundation (Flanders)
How to use drugs for pain management: from pharmacokinetics to pharmacogenomics
K Allegaert, JN van den Anker
European Journal of Pain Supplements 2 (1), 25-30, 2008
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Knowledge, attitude, and beliefs of medication use in pregnancy in an urban tertiary care center
J Kazma, T Araji, A Khilnani, J van den Anker, HK Ahmadzia
The Journal of Clinical Pharmacology 62, S30-S35, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program